Search News Archives
Follow us on
Conferences | Events

Media Partners

 

EUR 3 Million in Series A for the Growth and Development of Cytena GmbH

publication date: Apr 12, 2019
 | 
author/source: Cytena GmbH

EUR-3-Million-Series-A-Growth-Development-Cytena-GmbH


CytenaFreiburg-based Cytena GmbH successfully completes another financing round. In total, two private investors and High-Tech Gründerfonds (HTGF) are investing another 3 million euros in the company.

The new capital will be used to continue developing its single-cell printer lab technology, expand sales activities and tap into the potential of new applications more quickly.

The analysis of individual biological cells has rapidly gained in importance in recent years. Single cells are used in the development of modern drugs, so-called biopharmaceuticals, as well as in cancer and stem cell research. The Cytena family of single-cell printers consists of laboratory devices for handling and sorting individual viable cells. These instruments are innovative tools for the life sciences and make a long-term contribution to the development and manufacturing of new drugs.

"The technological advantage of our single-cell printers over competing products does not mean that we can rest on our laurels. Rather, our goal is to better understand and serve our customers' needs. The new capital creates an important basis for doing so,"says Cytena CFO Benjamin Steimle.In addition, the investment will help to increase the company’s market share. Although the majority of the world’s ten largest pharmaceutical companies are already customers of the Freiburg start-up, a very large global market potential is still waiting to be tapped.

Important milestones along this path so far have included a sales cooperation with a major American company and the addition of x.sight devices to the product family. "The recent financing round enables us to accelerate the next steps in Cytena's success story. "says Steimle.

Dr. Lena Krzyzak, Investment Manager at HTGF, says: "With our investment in series A, we intend to continue the successful growth of our start financing. The company has developed rapidly, and we have great confidence that the management team can continue expanding the market and continue product development.“

 

more about cytena




 


Popular this month

 

 

Renishaw Technology Used to Identify Microplastics in the Environment

 

Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384

 

You spoke, we listened – meet ASSIST PLUS

 

Tomocube 3D Microscope Captures Key Cellular Dynamic Responses to Parkinson Drug Treatment

 

Nine top companies awarded Pittcon 2019 Excellence Awards

 

New Gilson Benchtop Instruments, The Perfect Complement to Your Workflow

 

World’s First Voice-Powered Digital Assistant for Scientists

 

Pesticide Standard Mixtures for Cannabis Testing

 

Gene Editing Automation Collaboration

 

Extended spectrum of applications for centrifugation

 

 


 

Can't find what you are looking for?


Search by company or by product


Company Name:

Product:





Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd